Opana Er
Product Images NDC 21695-949
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Opana Er (NDC 21695-949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (B639732f 8eb2 4592 Aca3 86faf7e5360b 02)
Figure 2 (B639732f 8eb2 4592 Aca3 86faf7e5360b 03)
Opana Er 5mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 04)
This is a description of an opioid pain medication called Oxymorphone Hydrochloride ER Tablets. Each tablet contains 5mg of the active ingredient Oxymorphone Hydrochloride and is intended to be taken twice a day (every 12 hours) for pain relief. It is manufactured by Novartis Consumer Health Inc. and packaged by Physician Partner. The tablets are pink, octagon-shaped, film-coated, and have "5" debossed on one side and are plain on the other. It is important to store the medication at controlled room temperature and out of the reach of children.*
Opana Er 10mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 05)
Opana ER 10mg are light orange, octagon-shaped, film-coated, convex extended-release tablets used twice-a-day (every 12 hours). It contains Oxymorphone and Hydrochloride 10mg. Each tablet is debossed with 10" on one side and plain on the other. The product is packaged by Physician Partner and manufactured by Novartis Consumer Health Inc. The medication should be stored at a controlled room temperature of 15°C-30°C (59°F-86°F) and kept out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.